Preferred Name |
halobetasol |
Synonyms |
halobetasol propionate |
ID |
http://purl.bioontology.org/ontology/MESH/C064466 |
altLabel |
halobetasol propionate 21-chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 6 alpha-fluoroclobetasol 17-propionate CGP 14458 CGP-14458 6-fluoroclobetasol 17-propionate ulobetasol CGP 14 458 Ultravate |
cui |
C0082787 C0147791 C0098735 C0109195 |
Has mapping qualifier | |
HM |
D002990/Q000031 |
II |
D003879 D011565 |
Inverse of RB |
0 91A0K1TY3Z 9P6159HM7T |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19900711 |
MeSH Frequency |
90 |
MMR |
20170802 |
notation |
C064466 |
PA |
D014662 |
prefLabel |
halobetasol |
RR |
91A0K1TY3Z |
SC |
1 |
Scope Statement |
used in ointment to treat psoriasis; Ulobetasol cream contains 0.05% 6-fluoroclobetasol 17-propionate |
SRC |
Pharmacotherapy 1990;10(2):107 |
TERMUI |
T207565 T207558 T207560 T207564 T207562 T207559 T207563 T207561 T207566 |
TH |
US FDA SRS (2013) FDA SRS (2017) USAN (19XX) NLM (1990) CA INN (19XX) |
tui |
T109 T121 |